Trial intelligence / Profile preview

Reversal of brain changes in CRPS patients with treatment

2010-024558-12Phase 4Completed

Sponsor
Aalto University Brain Research Unit
Start
Jan 2011
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of memantine and morphine in Complex Regional Pain Syndrome Type 1 (CRPS-1) (2 arms), sponsored by Aalto University Brain Research Unit. Primary endpoint: Clinical improvement in CRPS. Started Jan 2011; status: completed.

02

Drugs

memantinemorphine
03

Conditions

Complex Regional Pain Syndrome Type 1 (CRPS-1)

Beyond the preview

Go deeper on 2010-024558-12.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2010-024558-12.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call